News

• Corporate Announcement

Ellume establishes flagship U.S. manufacturing facility in Maryland

• Ellume
• May 10, 2021

• Media

More at-home COVID tests coming to the market, and made in Maryland

• Ellume
• May 10, 2021

• Corporate Announcement

Over-the-counter COVID-19 testing now available at CVS Pharmacy

• Ellume
• April 20, 2021

• Corporate Announcement

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

• Ellume
• March 10, 2021

• Media

U.S. strikes $230 million deal for over-the-counter Covid tests

• Ellume
• February 2, 2021

• Media

A fast, at-home coronavirus test will be available to Americans this year

• Ellume
• February 2, 2021

• Media

U.S. Cuts $231 Million Deal To Provide 15-Minute COVID-19 At-Home Tests

• Ellume
• February 2, 2021

• Media

US Government signs deal to produce Australian COVID-19 Home Test kits

• Ellume
• February 2, 2021

• Corporate Announcement

Ellume Announces $231.8 Million Agreement with the U.S. Government

• Ellume
• February 1, 2021

• Media

BBC World Service Radio Brisbane Interview with Ellume CEO

• Ellume
• December 18, 2020

• Corporate Announcement

FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

• Ellume
• December 15, 2020

• Corporate Announcement

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

• Ellume
• December 10, 2020

• Media

ABC Radio “The Money” Interview with Ellume CEO, Dr Sean Parsons

• Ellume
• October 29, 2020

• Media

Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

• Ellume
• October 22, 2020

• Media

10 News First reports Ellume’s $42M NIH funding for rapid COVID test

• Ellume
• October 15, 2020

• Corporate Announcement

Ellume awarded US$30M from US National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

• Ellume
• October 7, 2020

• Corporate Announcement

Ellume announces high-performance test for active COVID-19 infection

• Ellume
• September 10, 2020

• Media

ABC Radio Brisbane Interview with Ellume CEO, Dr Sean Parsons

• Ellume
• September 8, 2020

• Media

Brisbane biotech company to send millions of COVID-19 tests to US

• Ellume
• September 3, 2020

• Media

Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

• Ellume
• September 3, 2020

• Media

Antibody test lab has designs on going global

• Ellume
• September 1, 2020

• Corporate Announcement

Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

• Ellume
• August 25, 2020

• Media

World TB Day 2020

• Ellume
• March 25, 2020

• Corporate Announcement

Ellume appoints Joanne Moss to its Board as Non-executive Director

• Ellume
• November 12, 2019

• Media

How Digital Diagnostics Are Changing Healthcare

• Ellume
• October 1, 2019

• Media

Ellume shines at AFR BOSS’ Most Innovative Companies Awards

• Ellume
• August 12, 2019

• Media

The 10 most innovative health companies

• Ellume
• August 9, 2019

• Media

From the emergency ward to pitching an IPO

• Ellume
• June 17, 2019

• Media

Flu-diagnostics startup Ellume raises $5 million as it gears up for IPO

• Ellume
• June 17, 2019

• Media

Ellume, the digital diagnostics company helping people beat the flu

• Ellume
• April 12, 2019

• Media

Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

• Ellume
• April 11, 2019

• Corporate Announcement

Ellume announces another global partnership with QIAGEN on the detection of tuberculosis

• Ellume
• January 8, 2019

• Media

Medical diagnostics firm Ellume gets German backing for TB testing

• Ellume
• January 7, 2019

• Media

Ellume spreads global wings with GSK deal

• Ellume
• December 11, 2018